The Features of Cornea Services in TVGH

1. Corneal transplantation
   1. Descemet Membrane Endothelial Keratoplasty (DMEK)
       Dr. Pei-Yu Lin with her patient who received DMEK surgery with great visual outcome
       
   2. Descemet Stripping Automated Endothelial Keratoplasty (DSAEK)
   3. Deep Anterior Lamellar Keratoplasty (DALK)
   4. Penetrating keratoplasty
        
2. Specialty contact lens fitting
   1. Contact lens fitting for astigmatism
   2. Contact lens fitting after refractive surgery 
   3. Contact lens fitting for keratoconus
   4. Scleral lens fitting
   5. Orthokeratology
       
3. Dry eye treatment
   1. Treatment of refractive dry eye disease
   2. Intense pulse light therapy (IPL) for meibomian gland dysfunction
   3. Autologous serum eye drops (ASEDs)
       
4. Special clinic for integrate myopia treatment
   1. Myopia prevention                                                                                                            
   2. Decrease myopia progression                   
   3. Complications management of pathological myopia     
                 
5. Refractive laser surgery                                                                        

   A.  Small Incision Lenticule Extraction (SMILE)

Meet Our Cornea Team:

Clinical trials

• -Optact” Large Diameter Rigid Gas Permeable Contact lens (Scleral lens) (Dr. Chih-Chien Hsu)
• - Revision 200 Overnight Wear Orthokeratology Contact Lens (Dr. Chih-Chien Hsu)
• - A Dose Range Phase II Study to Determine the Safety and Therapeutic Dose of SHJ002 Sterile Ophthalmic Solution in Pediatric Subjects aged 3-15 years (Dr. Chih-Chien Hsu)
• - Pathological Biomarker Research of Eye Diseases (Dr. Chih-Chien Hsu)
• - Improving corneal ulcer outcomes with unbiased pathogen and antimicrobial resistance detection: collaboration with University of California, San Francisco (Dr. Nai-Wen Fan, Dr. Yih-Shiuan Kuo)
• - The impact of long-term eye makeup on evaporative dry eye disease (Dr. Jin-Yu Chang, Dr. Nai-Wen Fan)
• - Investigating the safety, efficacy, and pharmacokinetics of various dosing regimens of single-agent Belantamab Mafodotin in participants with relapsed or refractory multiple myeloma (subPI: Dr. Nai-Wen Fan, Dr. Yih-Shiuan Kuo)

Publications: